Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
Abstract Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer effects remain incompletely understood. In this study, we report that hsa_circ_0000647 (circSEC11A) is highly expressed...
Main Authors: | Dong Li, Wujie Wang, Bin Liu, Die Jin, Yang Wang, Guanghui He, Lei Guo, Wen Liu, Yuliang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-08-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-023-01593-w |
Similar Items
-
ZHX2 in health and disease
by: Na Li, et al.
Published: (2022-11-01) -
Safety and efficacy of CT-guided radioactive iodine-125 seed implantation as a salvage treatment for recurrent head and neck cancer after two or more courses of radiotherapy
by: Yue Li, et al.
Published: (2023-05-01) -
Computed tomography-guided iodine-125 radioactive seed implantation in small-cell lung cancer: A retrospective study
by: Mengjie Li, et al.
Published: (2022-12-01) -
EBNA3C interacts with Gadd34 and counteracts the unfolded protein response
by: Takada Kenzo, et al.
Published: (2009-12-01) -
Management of hyperthyroidism with radioactive iodine
by: T Premprapha, et al.
Published: (2006-08-01)